Concepedia

D. Lucas Kerr

DL

Statistics

Publications

14

Citations

1.4K

H-Index

13

Active since

2018

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Dana-Farber Cancer Institute

Chan Zuckerberg Initiative (United States)

The University of Texas MD Anderson Cancer Center

D. Lucas Kerr is an author at University of California, San Francisco specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2018–2024

14

Publications

14

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

Ashley Maynard, Caroline E. McCoach, Julia Rotow et al. · Cell · 2020 · 699 citations · Full text

, , +17

AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee et al. · Cancer Discovery · 2022 · 103 citations · Full text

, , +17

PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors

Sanju Sinha, Rahulsimham Vegesna, Sumit Mukherjee et al. · Nature Cancer · 2024 · 98 citations

, , +14

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Deborah R. Caswell, Philippe Gui, Manasi K. Mayekar et al. · Nature Genetics · 2023 · 87 citations · Full text

, , +17

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer

Franziska Haderk, Yu‐Ting Chou, Lauren Čech et al. · Nature Communications · 2024 · 87 citations · Full text

, , +17

1–5 of 14